Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Analyst consensus.
ACCE opinionTOMI Environmental Solutions Inc. Common Stock (TOMZ)
Fair value
Not available
ACCE price target
$1.10
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $1.46 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
36
out of 100
Analysts
100% buy
1 covering
P/E
0.0x
forward 13.6x
1-year return
-45.3%
Dividend yield
0.00%
TOMI Environmental Solutions Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
TOMI Environmental Solutions sells SteraMist, a hydrogen peroxide mist disinfection system used to decontaminate hospital rooms, and it earns recurring revenue from the consumables and service contracts that follow each unit. Its edge is the gross margin of 52.9%, which is high for a hardware-plus-consumables business and suggests the disinfectant cartridges carry real pricing power once a hospital or facility is installed. Revenue grew 117.9%, but the operating margin is still negative at -10.9% and return on equity is -168.8%, so the growth has not yet reached profitability. The score of 36/100 and a $15M market cap mean this is a micro-cap with thin liquidity and no index membership, so any work here should start with whether the margin structure can scale faster than the losses. The forward P/E of 12.0 against a trailing P/E of zero reflects a swing to expected earnings that the reader should verify against the company's guidance before giving it weight.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
severe
Negative free cash flow and equity
Free cash flow is -$1,332,229 against a $14M market cap, and ROE of -168.8% with debt/equity of 5.82 signals a thin, debt-heavy capital base that may need outside funding.
high
Net losses and five-year revenue decline
Net margin is -49.8% and operating margin -10.9%, while five-year revenue CAGR is -25.8%. Recent 117.9% YoY revenue growth has not yet shown up in earnings.
moderate
Thin institutional ownership
Institutions hold just 3.7% of shares, with insiders at 25.0%. Low institutional interest means limited liquidity and less independent scrutiny of the company.
AI research notes
AI-assisted·How I use AIWritten Oct 16, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 117.9% year over year in the latest 10-Q, a sharp reversal from a shrinking business.
The stock trades at a forward P/E of 12.0x, which is modest if the recent growth holds.
Why it could disappoint
The company still loses money, with a net margin of -49.8% and a return on equity of -168.8%.
Debt is high at 5.82 times equity, leaving little room if losses continue.
Free cash flow over the last twelve months was negative at -$1M, and the free cash flow yield is -8.2%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 13, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where TOMZ's valuation models land
Price
$1.46
Model fair valueConfidence: low
about $7.00
Model
Fair value
Upside
Analyst consensus
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores